A nurse is collecting data from a client who is taking lithium to treat bipolar disorder

1. Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241–251. [PMC free article] [PubMed] [Google Scholar]

2. Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry. 2011;72:156–167. [PubMed] [Google Scholar]

3. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry. 2013;14(3):154–219. [PubMed] [Google Scholar]

4. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar disorders; 2013;15(1):1–44. [PubMed] [Google Scholar]

5. National Institute for Health and Care Excellence. Bipolar disorder: The assessment and management of bipolar disorders in adults, children and young people in primary and secondary care. Draft for consultation, April 2014. http: //www.nice.org.uk/

6. American Psychiatric Association. Guideline Watch: Practice guideline for the treatment of patients with bipolar disorder. 2nd ed. Washington DC: American Psychiatric Association; 2005. [Google Scholar]

7. Goodwin GM. Evidence –based guidelines for treating bipolar disorder: revised second edition- recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009;23:346–388. [PubMed] [Google Scholar]

8. Cipriani Andrea, et al. “Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.” The Lancet 378.9799. 2011:1306–1315. [PubMed] [Google Scholar]

9. Fountoulakis KN, Kontis D, Gonda X, Yatham LN. A systematic review of the evidence on the treatment of rapid cycling bipolar disorder. Bipolar disorders. 2013;15(2):115–137. [PubMed] [Google Scholar]

10. Rao PG. An overview of Indian research in bipolar mood disorder. Indian Journal of Psychiatry. 2010;52(Suppl1):S173–S177. [PMC free article] [PubMed] [Google Scholar]

11. Avasthi A, Grover S, Aggarwal M. Research on mood stabilizers in India. Indian J Psychiatry. 2010;52(Suppl S3):355–61. [PMC free article] [PubMed] [Google Scholar]

12. Grover S, Avasthi A, Sinha V, Lakdawala B, Bathla M, Sethi S, Mathur D M, Kathuria P, Shah S, Baalasubramanian D S, Agarwal V, Deka K. Indian Psychiatric Society multicentric study: Prescription patterns of psychotropics in India. Indian J Psychiatry. 2014;56:253–64. [PMC free article] [PubMed] [Google Scholar]

13. Grover S, Avasthi A. Mood stabilizers in pregnancy and lactation. Indian J Psychiatry. 2015;57(Suppl S2):308–23. [PMC free article] [PubMed] [Google Scholar]

14. Tighe SK, Mahon PB, Potash JB. Predictors of Lithium Response in Bipolar Disorder. Therapeutic Advances in Chronic Disease. 2011;2(3):209–226. [PMC free article] [PubMed] [Google Scholar]

15. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646. [PubMed] [Google Scholar]

16. Malhi GS, Tanious M. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations. CNS Drugs. 2011;25(4):289–98. [PubMed] [Google Scholar]

17. Ng F, Hallam K, Lucas N, Berk M. The role of lamotrigine in the management of bipolar disorder. Neuropsychiatric disease and treatment. 2007;3(4):463. [PMC free article] [PubMed] [Google Scholar]

18. Bowden C. L, Asnis G. M, Ginsberg L. D, Bentley B, Leadbetter R, White R. Safety and tolerability of lamotrigine for bipolar disorder. Drug safety. 2004;27(3):173–184. [PubMed] [Google Scholar]

19. Tränkner A, Sander C, Schönknecht P. (2013). A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder. Neuropsychiatric disease and treatment. 2013;9:101. [PMC free article] [PubMed] [Google Scholar]

20. Tohen M, Zhang F, Taylor CC, Burns P, Zarate C, Sanger T, Tollefson G. A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. Journal of affective disorders. 2001;65(1):85–93. [PubMed] [Google Scholar]

21. Gao K, Gajwani P, Elhaj O, Calabrese JR. Typical and atypical antipsychotics in bipolar depression. The Journal of clinical psychiatry. 2005;66(11):1376–1385. [PubMed] [Google Scholar]

22. Gigante AD, Lafer B, Yatham LN. Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder. CNS drugs. 2012;26(5):403–420. [PubMed] [Google Scholar]

23. De Berardis D, Marini S, Carano A, Padovan Lang A, Cavuto M, Piersanti M, Di Giannantonio M. Efficacy and safety of long acting injectable atypical antipsychotics: a review. Current clinical pharmacology. 2013;8(3):256–264. [PubMed] [Google Scholar]

24. Chou YH, Chu PC, Wu SW, Lee JC, Lee YH, Sun IW, Yen YC. A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder. Clinical Psychopharmacology and Neuroscience. 2015;13(2):121. [PMC free article] [PubMed] [Google Scholar]

25. Joffe RT, MacQueen GM, Marriott M, Robb J, Begin H, Young LT. Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant. ActaPsychiatricaScandinavica. 2002;105(6):427–430. [PubMed] [Google Scholar]

26. Thase ME, Sachs GS. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biological psychiatry. 2000;48(6):558–572. [PubMed] [Google Scholar]

27. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. American Journal of Psychiatry. 2014;161:1537–47. [PubMed] [Google Scholar]

28. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M. Antidepressant-induced mania in bipolar patients: identification of risk factors. Journal of Clinical Psychiatry. 2001;62(4):249–255. [PubMed] [Google Scholar]

29. TohenM Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of general psychiatry. 2003;60(11):1079–1088. [PubMed] [Google Scholar]

30. McElroy SL. Prescribing antidepressants for bipolar depression: what does the evidence say? The Journal of clinical psychiatry. 2014;75(9):e24–e24. [Google Scholar]

31. Silverstone T. Moclobemide vs. imipramine in bipolar depression: a multicentre double-blindclinical trial. ActapsychiatricaScandinavica. 2001;104(2):104–109. [PubMed] [Google Scholar]

32. Nivoli AM, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A, Vieta E. New treatment guidelines for acute bipolar depression: a systematic review. Journal of affective disorders. 2011;129(1):14–26. [PubMed] [Google Scholar]

33. Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment of bipolar depression. International Journal of Neuropsychopharmacology. 2013;16(7):1673–1685. [PubMed] [Google Scholar]

34. Schöttle D, Huber CG, Bock T, Meyer TD. Psychotherapy for bipolar disorder: a review of the most recent studies. Current opinion in psychiatry. 2011;24(6):549–555. [PubMed] [Google Scholar]

35. Scott JAN, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Hayhurst H. Cognitive–behavioural therapy for severe and recurrent bipolar disorders. The British Journal of Psychiatry. 2006;188(4):313–320. [PubMed] [Google Scholar]

36. Miklowitz DJ. A review of evidence-based psychosocial interventions for bipolar disorder. Journal of Clinical Psychiatry. 2006;67:28. [PubMed] [Google Scholar]

37. Chanpattana W. Combined ECT and clozapine in treatment-resistant mania. J ECT. 2000;16:204–207. [PubMed] [Google Scholar]

38. Devanand DP, Polanco P, Cruz R, Shah S, Paykina N, Singh K, Majors L. The efficacy of ECT in mixed affective states. J ECT. 2000;16:32–37. [PubMed] [Google Scholar]

39. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry. 1994;151:169–176. [PubMed] [Google Scholar]

40. Ismail Shihabuddeen TM, Gopinath PS. Group meetings of caretakers of patients with schizophrenia and bipolar mood disorders. Indian J Psychiatry. 2005;47:153–6. [PMC free article] [PubMed] [Google Scholar]

41. Durgam S, Starace A, Li D, Migliore R, Ruth A, Németh G, Laszlovszky I. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Bipolar Disord. 2015;17:63–75. [PubMed] [Google Scholar]

42. Muneer A. The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review. Cureus. 2016 Apr;8(4):e562. [PMC free article] [PubMed] [Google Scholar]